Culture Media Optimization of Support Production and Di* View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2002-2007

FUNDING AMOUNT

2014705 USD

ABSTRACT

DESCRIPTION (provided by applicant): Human Embryonic Stem (HES) cells have great potential for the study of basic human development, as tools for the testing and discovery of human pharmaceuticals, and as replacement cells for transplantation therapies Progress in HES cell research will lead to better therapies for multiple diseases, such as birth defects, diabetes, Parkinson's, leukemia, heart diseases, and many other degenerative diseases. The WiCell Research Institute (WiCell) was established in 1999 to support HES cell research and to distribute HES cells to external researchers. During the past two years, WiCell has undertaken large-scale production of its five established HES cell lines for distribution to academic and commercial researchers. Current culture conditions for HES cells are sub-optimal and optimization of HES cell culture conditions will enhance our distribution efforts and the efforts of all researchers who work with HES cells. The specific aims of this proposal are to (1) Expand the five WiCell HES cell lines to quantities sufficient to meet the demand, perform quality control tests on the five lines, and make the cell lines and technical support available to researchers, and (2) Optimize the cell culture media used to culture HES cell lines to maximize their expansion and distribution and their utilization by researchers. These aims will be accomplished with (1) Tested HES cell expansion protocols; (2) Standard assays for the analysis of human pathogenic viruses, mycoplasma, genetic identity, and karyotype; and (3) A newly developed HES self-renewal differentiation assay using a genetically modified HES cell line that expresses green fluorescent protein (GFP) in undifferentiated HES cells, but not in their differentiated derivatives. The cell lines to be used in these studies are listed on the NIH registry as WA01, WA07, WA09, WA13, WA14 More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=7127263

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2206", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "USD", 
      "type": "MonetaryAmount", 
      "value": "2014705"
    }, 
    "description": "DESCRIPTION (provided by applicant): Human Embryonic Stem (HES) cells have great potential for the study of basic human development, as tools for the testing and discovery of human pharmaceuticals, and as replacement cells for transplantation therapies Progress in HES cell research will lead to better therapies for multiple diseases, such as birth defects, diabetes, Parkinson's, leukemia, heart diseases, and many other degenerative diseases. The WiCell Research Institute (WiCell) was established in 1999 to support HES cell research and to distribute HES cells to external researchers. During the past two years, WiCell has undertaken large-scale production of its five established HES cell lines for distribution to academic and commercial researchers. Current culture conditions for HES cells are sub-optimal and optimization of HES cell culture conditions will enhance our distribution efforts and the efforts of all researchers who work with HES cells. The specific aims of this proposal are to (1) Expand the five WiCell HES cell lines to quantities sufficient to meet the demand, perform quality control tests on the five lines, and make the cell lines and technical support available to researchers, and (2) Optimize the cell culture media used to culture HES cell lines to maximize their expansion and distribution and their utilization by researchers. These aims will be accomplished with (1) Tested HES cell expansion protocols; (2) Standard assays for the analysis of human pathogenic viruses, mycoplasma, genetic identity, and karyotype; and (3) A newly developed HES self-renewal differentiation assay using a genetically modified HES cell line that expresses green fluorescent protein (GFP) in undifferentiated HES cells, but not in their differentiated derivatives. The cell lines to be used in these studies are listed on the NIH registry as WA01, WA07, WA09, WA13, WA14", 
    "endDate": "2007-08-31T00:00:00Z", 
    "funder": {
      "id": "https://www.grid.ac/institutes/grid.429651.d", 
      "type": "Organization"
    }, 
    "id": "sg:grant.2622167", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "2622167"
        ]
      }, 
      {
        "name": "nih_id", 
        "type": "PropertyValue", 
        "value": [
          "R24RR017721"
        ]
      }
    ], 
    "inLanguage": [
      "en"
    ], 
    "keywords": [
      "humans", 
      "many other degenerative diseases", 
      "human pathogenic viruses", 
      "utilization", 
      "support production", 
      "WiCell HES cell lines", 
      "diabetes", 
      "replacement cells", 
      "embryonic stem", 
      "genetic identity", 
      "WiCell Research Institute", 
      "HES", 
      "commercial researchers", 
      "optimization", 
      "karyotype", 
      "aim", 
      "cell culture medium", 
      "undifferentiated hES cells", 
      "differentiated derivatives", 
      "hES cell lines", 
      "applicants", 
      "specific aim", 
      "HES self-renewal differentiation assay", 
      "birth defects", 
      "analysis", 
      "standard assay", 
      "proposal", 
      "cells", 
      "NIH registry", 
      "basic human development", 
      "researchers", 
      "transplantation therapies Progress", 
      "distribution", 
      "testing", 
      "heart disease", 
      "current culture conditions", 
      "quality control tests", 
      "expansion", 
      "green fluorescent protein", 
      "multiple diseases", 
      "WA01", 
      "efforts", 
      "quantity", 
      "HES cell culture conditions", 
      "sub", 
      "distribution efforts", 
      "WA13", 
      "best therapy", 
      "demand", 
      "Culture Media Optimization", 
      "discovery", 
      "human pharmaceuticals", 
      "WA14", 
      "WA07", 
      "hES cells", 
      "Parkinson's", 
      "mycoplasmas", 
      "years", 
      "tool", 
      "external researchers", 
      "line", 
      "WiCell", 
      "cell lines", 
      "leukemia", 
      "WA09", 
      "large-scale production", 
      "hES cell research", 
      "HES cell expansion protocols", 
      "great potential", 
      "study", 
      "technical support", 
      "Di*. DESCRIPTION"
    ], 
    "name": "Culture Media Optimization of Support Production and Di*", 
    "recipient": [
      {
        "id": "https://www.grid.ac/institutes/grid.439113.d", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "https://www.grid.ac/institutes/grid.439113.d", 
          "name": "WICELL RESEARCH INSTITUTE", 
          "type": "Organization"
        }, 
        "familyName": "JONES", 
        "givenName": "JEFFREY MICHAEL", 
        "id": "sg:person.0667320366.76", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.0667320366.76", 
        "roleName": "PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.2622167"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2019-03-07T12:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_16.xml.gz", 
    "startDate": "2002-05-01T00:00:00Z", 
    "type": "MonetaryGrant", 
    "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=7127263"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2622167'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2622167'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2622167'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2622167'


 

This table displays all metadata directly associated to this object as RDF triples.

116 TRIPLES      19 PREDICATES      94 URIs      86 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:grant.2622167 schema:about anzsrc-for:2206
2 schema:amount N5016388e956f4d6799fac6786c74bed0
3 schema:description DESCRIPTION (provided by applicant): Human Embryonic Stem (HES) cells have great potential for the study of basic human development, as tools for the testing and discovery of human pharmaceuticals, and as replacement cells for transplantation therapies Progress in HES cell research will lead to better therapies for multiple diseases, such as birth defects, diabetes, Parkinson's, leukemia, heart diseases, and many other degenerative diseases. The WiCell Research Institute (WiCell) was established in 1999 to support HES cell research and to distribute HES cells to external researchers. During the past two years, WiCell has undertaken large-scale production of its five established HES cell lines for distribution to academic and commercial researchers. Current culture conditions for HES cells are sub-optimal and optimization of HES cell culture conditions will enhance our distribution efforts and the efforts of all researchers who work with HES cells. The specific aims of this proposal are to (1) Expand the five WiCell HES cell lines to quantities sufficient to meet the demand, perform quality control tests on the five lines, and make the cell lines and technical support available to researchers, and (2) Optimize the cell culture media used to culture HES cell lines to maximize their expansion and distribution and their utilization by researchers. These aims will be accomplished with (1) Tested HES cell expansion protocols; (2) Standard assays for the analysis of human pathogenic viruses, mycoplasma, genetic identity, and karyotype; and (3) A newly developed HES self-renewal differentiation assay using a genetically modified HES cell line that expresses green fluorescent protein (GFP) in undifferentiated HES cells, but not in their differentiated derivatives. The cell lines to be used in these studies are listed on the NIH registry as WA01, WA07, WA09, WA13, WA14
4 schema:endDate 2007-08-31T00:00:00Z
5 schema:funder https://www.grid.ac/institutes/grid.429651.d
6 schema:identifier N20de028ec51e46c48bed0d8e4df60464
7 N5d0b94da01254ada8db549e87f608a4a
8 schema:inLanguage en
9 schema:keywords Culture Media Optimization
10 Di*. DESCRIPTION
11 HES
12 HES cell culture conditions
13 HES cell expansion protocols
14 HES self-renewal differentiation assay
15 NIH registry
16 Parkinson's
17 WA01
18 WA07
19 WA09
20 WA13
21 WA14
22 WiCell
23 WiCell HES cell lines
24 WiCell Research Institute
25 aim
26 analysis
27 applicants
28 basic human development
29 best therapy
30 birth defects
31 cell culture medium
32 cell lines
33 cells
34 commercial researchers
35 current culture conditions
36 demand
37 diabetes
38 differentiated derivatives
39 discovery
40 distribution
41 distribution efforts
42 efforts
43 embryonic stem
44 expansion
45 external researchers
46 genetic identity
47 great potential
48 green fluorescent protein
49 hES cell lines
50 hES cell research
51 hES cells
52 heart disease
53 human pathogenic viruses
54 human pharmaceuticals
55 humans
56 karyotype
57 large-scale production
58 leukemia
59 line
60 many other degenerative diseases
61 multiple diseases
62 mycoplasmas
63 optimization
64 proposal
65 quality control tests
66 quantity
67 replacement cells
68 researchers
69 specific aim
70 standard assay
71 study
72 sub
73 support production
74 technical support
75 testing
76 tool
77 transplantation therapies Progress
78 undifferentiated hES cells
79 utilization
80 years
81 schema:name Culture Media Optimization of Support Production and Di*
82 schema:recipient Na1283e11fa7e4817b7b9adaeedbf56b4
83 sg:person.0667320366.76
84 https://www.grid.ac/institutes/grid.439113.d
85 schema:sameAs https://app.dimensions.ai/details/grant/grant.2622167
86 schema:sdDatePublished 2019-03-07T12:04
87 schema:sdLicense https://scigraph.springernature.com/explorer/license/
88 schema:sdPublisher Nc7ac305b34e44666b69f6a104b67cb14
89 schema:startDate 2002-05-01T00:00:00Z
90 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=7127263
91 sgo:license sg:explorer/license/
92 sgo:sdDataset grants
93 rdf:type schema:MonetaryGrant
94 N20de028ec51e46c48bed0d8e4df60464 schema:name dimensions_id
95 schema:value 2622167
96 rdf:type schema:PropertyValue
97 N5016388e956f4d6799fac6786c74bed0 schema:currency USD
98 schema:value 2014705
99 rdf:type schema:MonetaryAmount
100 N5d0b94da01254ada8db549e87f608a4a schema:name nih_id
101 schema:value R24RR017721
102 rdf:type schema:PropertyValue
103 Na1283e11fa7e4817b7b9adaeedbf56b4 schema:member sg:person.0667320366.76
104 schema:roleName PI
105 rdf:type schema:Role
106 Nc7ac305b34e44666b69f6a104b67cb14 schema:name Springer Nature - SN SciGraph project
107 rdf:type schema:Organization
108 anzsrc-for:2206 schema:inDefinedTermSet anzsrc-for:
109 rdf:type schema:DefinedTerm
110 sg:person.0667320366.76 schema:affiliation https://www.grid.ac/institutes/grid.439113.d
111 schema:familyName JONES
112 schema:givenName JEFFREY MICHAEL
113 rdf:type schema:Person
114 https://www.grid.ac/institutes/grid.429651.d schema:Organization
115 https://www.grid.ac/institutes/grid.439113.d schema:name WICELL RESEARCH INSTITUTE
116 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...